Mira Pharmaceuticals, Inc. (MIRA) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 24 institutional investors hold a position in Mira Pharmaceuticals, Inc. (NASDAQ:MIRA).

• The collective stake of institutional investors in Mira Pharmaceuticals moved to 10.2% in December 2025, a shift up from the 7.1% reported for September 2025.
• Institutional share ownership changed by 119.98% QoQ, while the number of institutional owners saw no change YoY.
• The latest 13F cycle for Mira Pharmaceuticals reveals that of 24 total investors, 12 funds grew their exposure, whereas 1 reduced theirs and 11 made no changes.
• The aggregate institutional position in Mira Pharmaceuticals now stands at 1.96Mn shares as of December 2025, after investors increased their holdings (up by 1.07Mn shares quarter on quarter which is up 866.38K shares year over year).
• As of December 31, 2025, VANGUARD GROUP INC held Mira Pharmaceuticals's largest shareholding position with over 660.50K shares, representing 3.43% of total outstanding shares.
• Among the most significant buyers of Mira Pharmaceuticals during December 2025 were VANGUARD GROUP INC (456.85K), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. (312.78K), GEODE CAPITAL MANAGEMENT, LLC (136.44K), Suncoast Equity Management (103.29K), NORTHERN TRUST CORP (23.97K).
• Leading sellers of Mira Pharmaceuticals stock in December 2025 included TWO SIGMA INVESTMENTS, LP (18.66K).
• The top 10 institutional holders of Mira Pharmaceuticals for the quarter ending December 2025 included VANGUARD GROUP INC (660.50K), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. (312.78K), GEODE CAPITAL MANAGEMENT, LLC (272.88K), Suncoast Equity Management (206.58K), BlackRock, Inc. (109.77K), NORTHERN TRUST CORP (67.70K), First American Bank (60.00K), STATE STREET CORP (49.10K), INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (35.00K), COMMONWEALTH EQUITY SERVICES, LLC (30.19K).